Julie Spellman Sweet just made a big buy of their own company's stock.

1. The buy: Chair and CEO at Accenture plc, 12,200 shares of ACN on 26 October 2026 -- $3,001,041 at $245.99 a share.
2. The entry: that price is real, not an estimate -- a Form 4 discloses the price actually paid, so this is their fill. It is what they paid on their own trade date, though, not a price available now.

Other insiders at ACN bought the same day: Paula A Price (Director, $199,848). They filed at their own prices, which is what separates several people deciding from one transaction written up under several names.
3. Filed: 28 October 2026.

Risk: one person buying a lot is the whole signal here. Grants, option exercises, tax withholdings and scheduled 10b5-1 plan purchases are excluded, since none of them is somebody choosing to put money in today; so are purchases by holders who are neither officers nor directors, which are funds building a position rather than a person making a decision. An automated tracker of public SEC filings, not a recommendation.